Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
CMSD
0.1140
The Fort Worth Press - Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
USD
-
AED 3.672504
AFN 64.000368
ALL 80.878301
AMD 368.276037
ANG 1.789884
AOA 918.000367
ARS 1391.78814
AUD 1.37836
AWG 1.8025
AZN 1.70397
BAM 1.65809
BBD 2.008732
BDT 122.377178
BGN 1.668102
BHD 0.376584
BIF 2968.504938
BMD 1
BND 1.264635
BOB 6.891611
BRL 4.915095
BSD 0.997329
BTN 94.180832
BWP 13.389852
BYN 2.818448
BYR 19600
BZD 2.00585
CAD 1.36715
CDF 2265.000362
CHF 0.776755
CLF 0.022636
CLP 890.873638
CNY 6.80075
CNH 6.796265
COP 3727.014539
CRC 458.479929
CUC 1
CUP 26.5
CVE 93.480565
CZK 20.636704
DJF 177.601628
DKK 6.340404
DOP 59.310754
DZD 132.326735
EGP 52.579797
ERN 15
ETB 155.726591
EUR 0.84804
FJD 2.18304
FKP 0.733957
GBP 0.733272
GEL 2.67504
GGP 0.733957
GHS 11.234793
GIP 0.733957
GMD 73.503851
GNF 8750.794795
GTQ 7.614768
GYD 208.672799
HKD 7.83165
HNL 26.513501
HRK 6.393304
HTG 130.575219
HUF 300.190388
IDR 17377.45
ILS 2.901304
IMP 0.733957
INR 94.425504
IQD 1306.515196
IRR 1311500.000352
ISK 122.010386
JEP 0.733957
JMD 157.187063
JOD 0.70904
JPY 156.678504
KES 128.803357
KGS 87.420504
KHR 4001.526006
KMF 418.00035
KPW 899.983822
KRW 1461.810383
KWD 0.30766
KYD 0.831164
KZT 460.946971
LAK 21871.900301
LBP 89311.771438
LKR 321.097029
LRD 183.01047
LSL 16.361918
LTL 2.95274
LVL 0.60489
LYD 6.306642
MAD 9.121445
MDL 17.054809
MGA 4165.995507
MKD 52.257217
MMK 2099.83295
MNT 3581.379784
MOP 8.041456
MRU 39.863507
MUR 46.820378
MVR 15.403739
MWK 1729.049214
MXN 17.177604
MYR 3.921039
MZN 63.910377
NAD 16.361918
NGN 1365.000344
NIO 36.700437
NOK 9.209304
NPR 150.68967
NZD 1.682794
OMR 0.384681
PAB 0.997329
PEN 3.448264
PGK 4.404222
PHP 60.515038
PKR 277.958713
PLN 3.59545
PYG 6092.153787
QAR 3.645458
RON 4.426304
RSD 99.504048
RUB 74.053665
RWF 1462.082998
SAR 3.767486
SBD 8.019432
SCR 14.874401
SDG 600.503676
SEK 9.215704
SGD 1.267404
SHP 0.746601
SLE 24.650371
SLL 20969.496166
SOS 569.963122
SRD 37.399038
STD 20697.981008
STN 20.770633
SVC 8.727057
SYP 110.56358
SZL 16.351151
THB 32.203038
TJS 9.305159
TMT 3.5
TND 2.896867
TOP 2.40776
TRY 45.347504
TTD 6.759357
TWD 31.316038
TZS 2598.109449
UAH 43.809334
UGX 3737.018354
UYU 39.777881
UZS 12097.83392
VES 499.23597
VND 26308
VUV 118.45862
WST 2.707065
XAF 556.107838
XAG 0.012445
XAU 0.000212
XCD 2.70255
XCG 1.797465
XDR 0.69162
XOF 556.107838
XPF 101.106354
YER 238.625037
ZAR 16.38071
ZMK 9001.203584
ZMW 18.98775
ZWL 321.999592
- Canary Islands brace for arrival of hantavirus-hit cruise ship
- Bagnaia pips Marquez to French Grand Prix pole
- Tchouameni can play Clasico despite Valverde clash: Real Madrid's Arbeloa
- Conflict inflames tensions at Venice Biennale of Art
- 'No home left' for Gazans stranded in West Bank since Oct 7
- Putin says army fighting 'aggressive' NATO-backed force in Victory Parade address
- Indonesia rescuers search for hikers killed in volcanic eruption
- Magyar to become Hungary's 'regime change' PM
- Wembanyama powers Spurs past T-Wolves as Knicks beat Sixers
- Moscow to hold scaled-back Victory Day parade as Ukraine truce kicks in
Emerging Growth Research Releases Flash Report on SBC Medical Group; Reiterates Buy-Extended Rating and $9.00 Price Target
NEW YORK CITY, NY / ACCESS Newswire / April 22, 2026 / Emerging Growth Research today announced the release of a Flash Report on SBC Medical Group Holdings, Inc. (NASDAQ:SBC), reiterating its Buy-Extended rating and maintaining its 12-month price target of $9.00, representing potential upside from the Company's recent share price of $3.65 as of April 21, 2026.
The Flash Report provides an update following recent share price volatility tied to a secondary share transaction, while reaffirming the Company's long-term growth outlook and underlying fundamentals.
Key Highlights from the Flash Report:
Secondary Share Transaction Misinterpreted by Market: SBC recently completed a secondary share issuance reflecting approximately a 3% reduction in the founder's ownership stake. Importantly, the transaction did not result in shareholder dilution, though shares declined following the offering due to the discounted pricing.
Founder Alignment Remains Strong: Despite the transaction, the founder/CEO continues to hold a significant majority stake in the Company, reinforcing long-term alignment with shareholders.
Improved Share Liquidity: The increase in public float-potentially up to 20%-is expected to enhance trading liquidity and may support broader institutional participation.
Potential Index Inclusion Catalyst: Increased float-adjusted market capitalization could improve SBC's eligibility for inclusion in the Russell Index.
Growth Recovery Expected in 2026: Following pricing-related revenue pressure in 2025, management continues to target a return to revenue growth during 2026.
Strategic Expansion Initiatives: SBC is pursuing international M&A opportunities and new initiatives in AI-driven operations and longevity-focused services.
Attractive Valuation: The recent share price pullback has created a disconnect between valuation and fundamentals, supported by a strong net cash position.
For a copy of the full Flash Report, please visit:
https://emerginggrowth.com/wp-content/uploads/2026/04/SBC_Flash-Report_4.22.26.pdf
Or
https://www.EmergingGrowth.com/profile/sbc/ (on the right side of the page as you scroll down)
About SBC Medical Group
SBC Medical Group Holdings, Inc. provides management services to cosmetic treatment centers through a franchise model, operating across Japan, Southeast Asia, and the United States.
About Emerging Growth Research
Emerging Growth Research is an independent equity research firm providing institutional-quality analysis on emerging growth companies.
Contact:
Emerging Growth Research
[email protected]
www.EmergingGrowth.com
Forward-Looking Statements
This press release contains forward-looking statements concerning business operations, financial performance, and future expectations of SBC Medical Group Holdings, Inc. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
SOURCE: SBC Medical Group Holdings Incorporated
View the original press release on ACCESS Newswire
P.Grant--TFWP
